JASPER THERAPEUTICS, INC. Public Float
JASPER THERAPEUTICS, INC. (JSPR) had Public Float of $74.80 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $74.80M.
- 2024-06-30: Entity Public Float $281.00M.
- 2023-06-30: Entity Public Float $110.50M.
- 2022-06-30: Entity Public Float $48.70M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $74.80M 10-K/A · filed 2026-04-30 |
| 2024-06-30 | $281.00M 10-K · filed 2025-02-28 |
| 2023-06-30 | $110.50M 10-K · filed 2024-03-05 |
| 2022-06-30 | $48.70M 10-K · filed 2023-03-08 |
| 2021-06-30 | $99.40M 10-K · filed 2022-03-18 |
| 2020-06-30 | $102.50M 10-K/A · filed 2021-05-24 |
| 2019-06-28 | $100.70M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |